$CRDF
Cardiff Oncology, Inc. Stock $crdf

$crdf Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000162828017002601 Filed on March 15, 2017

Income Statement

Concept	2015 Q4	2015 Q3	2015 Q2
Revenue	$79.00K	$58.00K	$49.00K
YoY Change	41.07%	1.75%	-12.5%
Cost Of Revenue	$200.0K	$173.5K	$80.03K
YoY Change	900.0%
Gross Profit	-$120.0K	-$115.5K	-$31.03K
YoY Change	-400.0%	-302.7%
Gross Profit Margin	-151.9%	-199.2%	-63.33%
Selling, General & Admin	$4.150M	$3.747M	$3.917M
YoY Change	16.25%	86.67%	106.18%
% of Gross Profit
Research & Development	$3.110M	$2.547M	$2.684M
YoY Change	220.62%	27.95%	91.73%
% of Gross Profit
Depreciation & Amortization	$130.0K	$100.0K	$80.00K
YoY Change	116.67%	66.67%	33.33%
% of Gross Profit
Operating Expenses	$7.463M	$6.467M	$6.682M
YoY Change	63.66%	61.8%	102.67%
Operating Profit	-$7.583M	-$6.410M	-$6.632M
YoY Change	67.77%	62.67%
Interest Expense	$10.00K	$352.7K	-$3.560M
YoY Change	-105.56%	-9.53%	-264.81%
% of Operating Profit
Other Income/Expense, Net	-$10.00K	-$8.130K	$9.179K
YoY Change	-50.0%	-57.78%
Pretax Income	-$7.380M	-$2.740M	-$10.18M
YoY Change	57.69%	-49.07%	842.59%
Income Tax
% Of Pretax Income
Net Earnings	-$7.380M	-$2.736M	-$10.18M
YoY Change	57.69%	-49.1%	842.6%
Net Earnings / Revenue	-9341.77%	-4716.95%	-20775.58%
Basic Earnings Per Share	-$0.25	-$0.10	-$0.41
Diluted Earnings Per Share	-$0.26	-$0.23	-$0.41
COMMON SHARES
Basic Shares Outstanding	29.72M shares	28.56M shares	24.59M shares
Diluted Shares Outstanding	30.16M shares	29.13M shares	24.59M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.50M	$74.10M	$41.30M
YoY Change	147.25%	137.5%	19.02%
Cash & Equivalents	$67.49M	$74.15M	$41.29M
Short-Term Investments
Other Short-Term Assets	$800.0K	$600.0K	$500.0K
YoY Change	100.0%	100.0%	66.67%
Inventory
Prepaid Expenses
Receivables	$98.74K	$66.97K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$68.38M	$74.82M	$41.90M
YoY Change	146.69%	136.76%	19.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.691M	$1.842M	$1.400M
YoY Change	220.16%	130.28%	75.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$374.0K	$362.9K	$400.0K
YoY Change	11.08%	20.98%	33.33%
Total Long-Term Assets	$3.065M	$2.205M	$1.700M
YoY Change	160.35%	83.76%	41.67%
TOTAL ASSETS
Total Short-Term Assets	$68.38M	$74.82M	$41.90M
Total Long-Term Assets	$3.065M	$2.205M	$1.700M
Total Assets	$71.45M	$77.02M	$43.60M
YoY Change	147.24%	134.83%	20.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.041M	$1.100M	$1.100M
YoY Change	39.19%	120.01%	175.0%
Accrued Expenses	$1.904M	$2.124M	$1.500M
YoY Change	3.37%	11.79%	-6.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.200M	$3.700M	$2.300M
YoY Change	173.68%	362.5%
Total Short-Term Liabilities	$8.201M	$6.969M	$5.000M
YoY Change	82.73%	124.82%	150.0%
LONG-TERM LIABILITIES
Long-Term Debt	$11.20M	$11.50M	$12.90M
YoY Change	-14.5%	-17.86%	-12.24%
Other Long-Term Liabilities	$0.00	$3.700M	$7.700M
YoY Change	-100.0%	12.12%	250.0%
Total Long-Term Liabilities	$0.00	$15.20M	$20.60M
YoY Change	-100.0%	-12.14%	21.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.201M	$6.969M	$5.000M
Total Long-Term Liabilities	$0.00	$15.20M	$20.60M
Total Liabilities	$22.74M	$22.16M	$25.50M
YoY Change	10.69%	8.65%	34.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$108.9M	-$101.5M
YoY Change	33.78%
Common Stock	$2.974K	$2.972K
YoY Change	57.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$48.70M	$54.86M	$18.10M
YoY Change
Total Liabilities & Shareholders Equity	$71.45M	$77.02M	$43.60M
YoY Change	147.24%	134.83%	20.44%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015 Q2
OPERATING ACTIVITIES
Net Income	-$7.380M	-$2.736M	-$10.18M
YoY Change	57.69%	-49.1%	842.6%
Depreciation, Depletion And Amortization	$130.0K	$100.0K	$80.00K
YoY Change	116.67%	66.67%	33.33%
Cash From Operating Activities	-$6.810M	-$5.130M	-$5.450M
YoY Change	75.97%	50.44%	105.66%
INVESTING ACTIVITIES
Capital Expenditures	-$980.0K	-$570.0K	-$440.0K
YoY Change	716.67%	418.18%	4300.0%
Acquisitions
YoY Change
Other Investing Activities	$10.00K
YoY Change	-83.33%
Cash From Investing Activities	-$970.0K	-$570.0K	-$440.0K
YoY Change	1516.67%	418.18%	4300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.130M	38.55M	3.190M
YoY Change	1783.33%		-77.95%
NET CHANGE
Cash From Operating Activities	-6.810M	-5.130M	-5.450M
Cash From Investing Activities	-970.0K	-570.0K	-440.0K
Cash From Financing Activities	1.130M	38.55M	3.190M
Net Change In Cash	-6.650M	32.85M	-2.700M
YoY Change	71.83%	-1033.24%	-122.86%
FREE CASH FLOW
Cash From Operating Activities	-$6.810M	-$5.130M	-$5.450M
Capital Expenditures	-$980.0K	-$570.0K	-$440.0K
Free Cash Flow	-$5.830M	-$4.560M	-$5.010M
YoY Change	55.47%	38.18%	89.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001213037
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30965000	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	118688886	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	Trovagene, Inc.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	trov	Accruedresearchagreements Accruedresearchagreements	386267	USD
CY2016Q4	trov	Accruedresearchagreements Accruedresearchagreements	736199	USD
CY2014	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	-2422337	USD
CY2015	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	-4396061	USD
CY2016	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	-2321053	USD
CY2014	trov	Adjustments To Additional Paid In Capital Warrant Issued Debt Agreement AdjustmentsToAdditionalPaidInCapitalWarrantIssuedDebtAgreement	235857	USD
CY2016	trov	Adjustments To Additional Paid In Capital Warrant Issued Debt Agreement AdjustmentsToAdditionalPaidInCapitalWarrantIssuedDebtAgreement	148885	USD
CY2015	trov	Adjustments To Additional Paid In Capital Warrants Reclassified Amount AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedAmount	435365	USD
CY2014	trov	Adjustmentsto Additional Paidin Capital Warrants Reclassified Non Cash Portion Amount AdjustmentstoAdditionalPaidinCapitalWarrantsReclassifiedNonCashPortionAmount	0	USD
CY2015	trov	Adjustmentsto Additional Paidin Capital Warrants Reclassified Non Cash Portion Amount AdjustmentstoAdditionalPaidinCapitalWarrantsReclassifiedNonCashPortionAmount	-435365	USD
CY2015Q2	trov	Area Of Land After Expansion AreaOfLandAfterExpansion	26100	sqft
CY2015Q4	trov	Area Of Land After Expansion AreaOfLandAfterExpansion	2300	sqft
CY2014	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	36666	shares
CY2015	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	732378	shares
CY2016	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	8333	shares
CY2014	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	16667	shares
CY2015	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	50000	shares
CY2014	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	85470	shares
CY2015	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	30992	shares
CY2016	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	30992	shares
CY2013Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.87
CY2014Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.85
CY2015Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.86
CY2016Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.83
CY2014	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.00
CY2015	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.77
CY2016	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.00
CY2014	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	10.80
CY2015	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	8.00
CY2014	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	3.51
CY2015	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	4.84
CY2016	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	4.84
CY2014	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-14325484	USD
CY2015Q4	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-27471094	USD
CY2016Q4	trov	Comprehensive Income Loss Availableto Common Stockholders Basic ComprehensiveIncomeLossAvailabletoCommonStockholdersBasic	-39214492	USD
CY2015	trov	Decrease In Derivative Liability Due To Exercise Of Warrants DecreaseInDerivativeLiabilityDueToExerciseOfWarrants	435365	USD
CY2015Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	2000	USD
CY2016Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	2817	USD
CY2016	trov	Defined Contribution Plan Threshold Age Catch Up Contribution DefinedContributionPlanThresholdAgeCatchUpContribution	P50Y
CY2015	trov	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.01
CY2016	trov	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	0.00
CY2015	trov	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	258000	USD
CY2016	trov	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	-114000	USD
CY2014	trov	Leaseholdimprovementspaidforbylessor Leaseholdimprovementspaidforbylessor	0	USD
CY2015	trov	Leaseholdimprovementspaidforbylessor Leaseholdimprovementspaidforbylessor	0	USD
CY2016	trov	Leaseholdimprovementspaidforbylessor Leaseholdimprovementspaidforbylessor	1860000	USD
CY2016Q4	trov	Numberof Milestone Payments NumberofMilestonePayments	2	milestone_payment
CY2015Q2	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	68000	USD
CY2015Q4	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	3100	USD
CY2014Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	235857	USD
CY2016Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	148885	USD
CY2016Q3	trov	Original Value Of Warrants OriginalValueOfWarrants	148885	USD
CY2014	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	23015	USD
CY2015	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	24240	USD
CY2016	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	24240	USD
CY2016	trov	Share Based Compensation Number Of Options Issued Over Stock Option Authorized ShareBasedCompensationNumberOfOptionsIssuedOverStockOptionAuthorized	996000	shares
CY2015	trov	Stock Issued During Period Value Warrants Exercised Net StockIssuedDuringPeriodValueWarrantsExercisedNet	0	USD
CY2015	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-107261	USD
CY2016	trov	Stock Issued During Period Value Warrants Exercised Net StockIssuedDuringPeriodValueWarrantsExercisedNet	0	USD
CY2015	trov	Value Of Warrants Issued During Period For Cash Consideration ValueOfWarrantsIssuedDuringPeriodForCashConsideration	1389427	USD
CY2013	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P4Y5M23D
CY2014	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P3Y6M26D
CY2015	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P2Y6M11D
CY2016	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P1Y7M6D
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1040868	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1130536	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98736	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	100460	USD
CY2014	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2014	us-gaap	Accretion Of Discount AccretionOfDiscount	57117	USD
CY2015	us-gaap	Accretion Of Discount AccretionOfDiscount	88123	USD
CY2016	us-gaap	Accretion Of Discount AccretionOfDiscount	173803	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1903797	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4021365	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	421314	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	854782	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1761985	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10773	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	157585498	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167890984	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2070195	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3946027	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7504316	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2070194	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3946027	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7504316	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	248799	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	346157	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	390548	USD
CY2014	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	0	USD
CY2015	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	0	USD
CY2016	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	-201037	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10228257	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11577702	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10402359	shares
CY2015Q4	us-gaap	Assets Assets	71445651	USD
CY2016Q4	us-gaap	Assets Assets	43950411	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	68381068	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	38950192	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	374	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9439	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Short Term Investments Amortized Cost AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost	23987087	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25836937	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27293798	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67493047	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13915094	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6233483	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6265620	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5533242	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5505901	shares
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29737601	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30696791	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29737601	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30696791	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	2974	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	3070	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14348499	USD
CY2015Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27495334	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39238732	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	15441	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	629191	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	1730512	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5651000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9602000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-14035000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-114000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6100000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11344000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16592000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	30614	USD
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	285246	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1373717	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-449000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1742000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2443000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	34000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	50260	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41502	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1283	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4658	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6100000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11344000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16592000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	34000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	50260	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2014	us-gaap	Depreciation Depreciation	234813	USD
CY2015	us-gaap	Depreciation Depreciation	378711	USD
CY2016	us-gaap	Depreciation Depreciation	969833	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	234813	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	378711	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1069547	USD
CY2015Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3297077	USD
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	834940	USD
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock	23015	USD
CY2015	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24240	USD
CY2016	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24240	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.05
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.30
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.37
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5825	USD
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.42
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.43
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.00
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.00
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.03
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.03
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	896404	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2203876	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	0	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	24845	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4562	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-577314	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5810087	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7919826	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11475947	USD
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2016	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11638000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16996000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-114000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9340000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-13206000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1559000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2286000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	997000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1276000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	2400	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	16934	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	4560	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	632299	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	361432	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2157221	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22300	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	42042	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1724	USD
CY2014	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	0	USD
CY2015	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	0	USD
CY2016	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	84182	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	258	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	37296	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	789739	USD
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	216470	USD
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	420026	USD
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	277327	USD
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	166832	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	250452	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	106425	shares
CY2014	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-831020	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1468221	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1375512	USD
CY2014	us-gaap	Interest Paid InterestPaid	425256	USD
CY2015	us-gaap	Interest Paid InterestPaid	1061993	USD
CY2016	us-gaap	Interest Paid InterestPaid	1103677	USD
CY2015Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P3Y
CY2015Q4	us-gaap	Liabilities Liabilities	22744362	USD
CY2016Q4	us-gaap	Liabilities Liabilities	24182272	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71445651	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43950411	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8201097	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7797256	USD
CY2014	us-gaap	License And Services Revenue LicenseAndServicesRevenue	10000	USD
CY2016	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
CY2016Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	626104	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	11246188	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14176359	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	5225818	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2360109	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1232534	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1456861	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	40199249	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-53577953	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	14484036	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	64551740	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2301376	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-299790	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2233466	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-24833649	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12727385	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-22119025	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31039855	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-14325484	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-27471094	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-39203719	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14348499	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7180000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10186000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7600	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2742000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7387000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27495334	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10269000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10208000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10197000	USD
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8554000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39227959	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16770836	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31891395	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-41549012	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	15225337	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	4975000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	6682000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	6467000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	7463000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	25586464	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	10579000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	10084000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	10013000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	9850000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	40526683	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-14945159	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-25273652	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-40145611	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4612538	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	896050	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	959401	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	931457	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	906879	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	918751	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2016	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	306066	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	315000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	471000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	602000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	621126	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	659976	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	374004	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1173304	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2015Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2016Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1708	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1708	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10773	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2015Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2016Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-9065	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-9065	USD
CY2014	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	24845	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2800	USD
CY2016	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-144733	USD
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	24375	USD
CY2016	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	36873	USD
	us-gaap	Payments For Fees PaymentsForFees	0	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	37760166	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	363290	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2241066	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	823483	USD
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	23015	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	24240	USD
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	24240	USD
CY2015Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2016Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	789285	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	956616	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	61215399	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2285415	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7805085	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2400000	USD
CY2015	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1086062	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	792251	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	13750000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	63500	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	860852	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	366966	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1389427	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3545361	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5588900	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2690579	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3826915	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8896166	USD
CY2014	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	515964	USD
CY2015	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	52175	USD
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6664906	USD
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10593869	USD
CY2016	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	15006642	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	790438	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	418000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108887243	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148115202	USD
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	270178	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	274648	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	258062	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	280178	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	127000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	49000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	58000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	79000	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	312812	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	120000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	104000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	89000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	68000	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	381072	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	0	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	13789	USD
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	86137	USD
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2734903	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6443578	USD
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11523144	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	2070194	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	3946027	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	7504316	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1382255	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1932799	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	293781	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1960256	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2634688	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6261655	USD
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	23978022	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	61215399	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2285415	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	860852	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	366966	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	20392000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	8349553	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	48701289	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	19768139	USD
CY2014	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1425850	USD
CY2015	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-726421	USD
CY2016	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2462137	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19071112	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21817710	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24592883	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29128235	shares
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30157038	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26452165	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30108377	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29958037	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30339774	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30711946	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30281263	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18904280	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21817710	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24592883	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28560211	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29723254	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26201713	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29755184	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29958037	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30339774	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30639440	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30174838	shares
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and short-term investments. The Company maintains deposit accounts at financial institutions that are in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash due to the financial position of the depository institution in which those deposits are held. We limit our exposure to credit loss by generally placing our cash and short-term investments in high credit quality financial institutions and investment in fixed income instruments denominated and payable in U.S. dollars. Additionally, we have established guidelines regarding diversification of our investments and their maturities, which are designed to maintain principal and maximize liquidity.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-17-002601-index-headers.html	Edgar Link	pending
0001628280-17-002601-index.html	Edgar Link	pending
0001628280-17-002601.txt	Edgar Link	pending
0001628280-17-002601-xbrl.zip	Edgar Link	pending
exhibit1034q42016.htm	Edgar Link	pending
exhibit21q42016.htm	Edgar Link	pending
exhibit231q42016.htm	Edgar Link	pending
exhibit311q42016.htm	Edgar Link	pending
exhibit321q42016.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
performancegraph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trov-123116x10k.htm	Edgar Link	pending
trov-20161231.xml	Edgar Link	completed
trov-20161231.xsd	Edgar Link	pending
trov-20161231_cal.xml	Edgar Link	unprocessable
trov-20161231_def.xml	Edgar Link	unprocessable
trov-20161231_lab.xml	Edgar Link	unprocessable
trov-20161231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRDF
Cardiff Oncology, Inc. Stock $crdf

2015 Q4 Form 10-K Financial Statement

#000162828017002601 Filed on March 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF Cardiff Oncology, Inc. Stock $crdf

2015 Q4 Form 10-K Financial Statement

#000162828017002601 Filed on March 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF
Cardiff Oncology, Inc. Stock $crdf